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Valvular heart disease associated with rheumatoid arthritis is rare. In some cases, patho-
logical studies have shown valve nodules and leaﬂet ﬁbrosis that may extend to both
the valvular annulus and, in the case of atrioventricular valves, the subvalvular appara-
tus. Valve regurgitation is common, but there are only few reports on valve stenosis. We
report a case of rapid progression of aortic stenosis in a 67-year-old woman with long-
standing active, uncontrolled and erosive rheumatoid arthritis for which an antitumour
necrosis factor (TNF)  therapy had been initiated. She had a 3-year history of stable
asymptomatic moderate aortic stenosis (Fig. 1, Panel A) (maximal velocity: 2.3m/sec
and 2.7m/sec, mean gradient: 17 and 22mmHg, aortic surface area: 0.8 cm2/m2 and
0.7 cm2/m2, respectively, 3 years and 3months before the acute event). An episode of
acute heart failure occurred 5 days after the ﬁrst infusion of etanercept. Transthoracic
echocardiography revealed marked deterioration of the left ventricular ejection frac-
tion (25—30%) and now severe low gradient aortic stenosis (mean gradient: 20mmHg,
calculated aortic surface area 0.5 cm2/m2). Ejection fraction had been normal 3 months
before the acute decompensation. The anti-TNF  therapy was interrupted. Low-doserhumatoïde ;
Échocardiographie de
stress à faibles doses
de dobutamine
dobutamine-stress echocardiography revealed residual contractile reserve and conﬁrmed
‘‘true’’ severe aortic stenosis (Fig. 1, Panel B). Aortic-valve replacement was performed
after ruling out coronary artery disease by coronary angiography. The operative settings
showed three thickened leaﬂets and valve nodules. Histological examination conﬁrmed
the presence of rheumatoid nodules (Fig. 1, Panel C-a) showing large epitheloid cells
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aigure 1. Panel A. Parasternal long-axis view of the aortic-valv
obutamine-stress echocardiography showing residual contractile
oxylin and eosine) showing (a) large epitheloid cells (arrow) and ne
ssociated with (b) leaﬂet ﬁbrosis and calciﬁcations (squares and a
arrow) and neutrophilic granulocytes (arrowhead) in a
ackground of ﬁbrin (asterisk) associated with leaﬂet ﬁbro-
is and calciﬁcations (squares and arrow, respectively, in
ig. 1, Panel C-b). Because of poor control of the rheuma-
oid arthritis, the etanercept therapy was reintroduced,
ithout recurrence of cardiac symptoms. At follow-up
months after surgery the ejection fraction had recovered
ompletely.
To our knowledge there are no data available linking
ctive rheumatoid arthritis with fast progression of aortic
e
C
Nrow) showing thickened and calciﬁed leaﬂets. Panel B. Low-dose
ve and ‘‘true’’ severe aortic stenosis. Panel C. Histology (haema-
philic granulocytes (arrowhead) in a background of ﬁbrin (asterisk)
respectively).
tenosis. Previously reported risk factors for rapid progres-
ion are older age, high maximal velocity (>4—4.5m/sec),
ortic leaﬂet calciﬁcation, pathological exercise stress test,
ardiovascular risk factors such as hypercholesterolaemia
nd smoking, renal failure or dialysis, hypercalcaemia and
levated C-reactive protein.
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